Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Sequenced Behavioral and Medication Intervention For Cocaine Dependence
Behavioral therapy in combination with medication treatment (if needed) for cocaine dependence
Sponsor:National Institute on Drug Abuse
Enrolling:Male and Female Patients
Study Length:14 Weeks
Clinic Visits:42
Age Range:Between 18 and 60 years old
IRB Number:6850
U.S. Government ID:NCT01986075
Contact: Daniel Brooks: 212-923-3031 /
Additional Study Information:

This study will test a computer-based behavioral intervention to decrease cocaine use. Those who fail to achieve cocaine abstinence after the first 4 weeks while receiving the behavioral treatment will continue the behavioral treatment and be randomly assigned to one of two groups (one group will receive Adderall-XR (MAS-ER) and the other group will receive placebo (an inactive sugar pill)), over the course of 10 weeks. Patients will be asked to come into the clinic for outpatient treatment 3 times per week.

Do You Qualify?
Are you currently using cocaine?YesNo
Have you used cocaine at least 4 days in the last month?YesNo
Are you between the ages of 18 and 60?YesNo
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Daniel Brooks
Phone: 212-923-3031